Les Miranda, Executive Director Research Amgen Marian Gindy, Director Sterile Formulation Sciences Merck Alan Mathiowetz, Director Pfizer Todd Page, Director of Toxicology Eli Lilly Vivian Lindo, Associate Director Product Characterisation MedImmune Natia Tsomaia, Associate Director Ipsen Magnus Jaderberg, Chief Medical Officer Targovax Andy Parker, Senior Vice President and Chief Scientific Officer Zealand Pharma Jesse Dong, Vice President Peptide Chemistry Neon Therapeutics Daniel O’Brecht, Chief Scientific Officer Polyphor Mette Svendgaard, Director Pharmaceutical Development Zealand Pharma Marc Thommen, Head of Chemistry Polyphor Frank Thielmann, PMO and Operational Excellence Platform Leader Novartis Stephen Buckley, Head of Discovery ADME Novo Nordisk Mathias Schaffrath, Group Head Chromatography Sanofi Lukas Leder, Lab Head Peptide Discovery Platform Novartis Claudio Mapelli, Principal Scientist Merck William Drury, Associate Principal Scientist AstraZeneca Mohamed ElSayed, Senior Research Advisor & Program Leader Eli Lilly Andreas Evers, Senior Scientist Sanofi Elizabeth Pierson, Senior Scientist Merck Thomas De Vijlder, Senior Scientist Janssen Ying-Kai Wang, Senior Research Investigator II Bristol Myers Squibb Liuhong Chen, Discovery Biology Team Leader Bicycle Therapeutics Ltd Cedric Fiez-Vandal, Senior Scientist Heptares Therapeutics Johannes Urban, Senior Scientist Technology Development Morphosys Hao Luo, Associate Principal Scientist Merck David Craik, Professor & Group Leader, Chemistry and Structural Biology University of Queensland Michal Bassani-Sternberg, Head of Immunopeptidomics Unit, Department of Oncology University Hospital of Lausanne (CHUV), Switzerland and the Ludwig Institute for Cancer Research Steven Ballet, Professor Free University Brussels Mark Howarth, Associate Professor University of Oxford
|